Dobutamine stress echocardiography: the long and short of it.

enteroviruses with human heart disease. Heart 1997; 78: 539–43. [4] Horwitz MS, La Cava A, Fine C et al. Pancreatic expression of interferonprotects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nature Med 2000; 6: 693–7. [5] Brown LJ, Illavia SJ, Hayat SA, Banatvala JE, Muir P. Viral persistence and antigen expression in coxsackievirus-induced acute and chronic murine myocarditis. J Clin Virol 2001; 22: 150–1. [6] Li Y, Pan Z, Ji Y, Peng T, Archard LC, Zhang H. Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease. Eur Heart J 2002; 23: 567–73. [7] Li YW, Bourlet T, Andreoletti L et al. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis and dilated cardiomyopathy. Circulation 2000; 101: 231–4. [8] Zhang H, Li Y, Peng T et al. Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique. J Histochem Cytochem 2000; 48: 579–84. [9] Li YW, Yang YZ, Chen HZ. Relationship between enteroviral infection and chronic rheumatic valvular disease. Chin J Exp Surg 1997; 14: 163–4. [10] Li Y, Peng T, Yang Y et al. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 2000; 83: 696–701. [11] Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in seleniumdeficient mice results in selection of identical virulent isolates. Nature Med 1995; 1: 433–6. [12] Roberts S, Kosanke S, Dunn ST et al. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis 2001; 183: 507–11. [13] Chonmaitree T, Mann L. Respiratory infections. In: Rotbart HA, ed. Human enterovirus infections. Washington DC: ASM Press, 1995: 255–70. [14] Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997; 29: 77–84. [15] Cunningham MW, Antone SM, Gulizia JM et al. Cytotoxic and viral neutralizing antibodies cross react with streptococcal M protein, enteroviruses and human cardiac myosin. Proc Natl Acad Sci USA 1992; 89: 1320–4. [16] Horwitz MS, Bradley LM, Harbertson J et al. Diabetes induced by coxsackievirus: Initiation by bystander damage and not molecular mimicry. Nature Med 1998; 4: 781–5. [17] Luppi P, Rudert WA, Zanone MM et al. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation 1998; 98: 777–85. [18] Luppi P, Licata A, Haluszczak C et al. Analysis of TCR V repertoire and cytokine gene expression in patients with idiopathic dilated cardiomyopathy. J Autoimmun 2001; 16: 3–13. [19] Michie CA, Cohen J. The clinical significance of T-cell superantigens. Trends Microbiol 1998; 6: 61–5. [20] Papageorgiou AC, Acharya KR. Microbial superantigens: from structure to function. Trends Microbiol 2000; 8: 369–75. [21] Schiffenbauer J, Johnson HM, Butfiloski EJ, Wegrzyn L, Soos JM. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 1993; 90: 8543–6. [22] Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253: 325–9. [23] Conrad B, Weidmann E, Trucco G et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351–5. [24] Guilherme L, Dulphy N, Douay C et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol 2000; 12: 1063–74.